ABSTRACT: A unified and common intermediate strategy for syntheses of juglomycins and their derivatives is reported. The use of a 1,4-dimethoxynaphthalene derivative as a key intermediate enabled easy access to various juglomycin derivatives. In this study, juglomycins A−D, juglomycin C amide, khatmiamycin and its 4-epimer, and the structure proposed for juglomycin Z were synthesized from this intermediate. The absolute configuration of natural khatmiamycin has been established to be 3R,4R through our synthesis. Unfortunately, the spectroscopic data for synthetic juglomycin Z were not consistent with the data reported for the natural one, strongly suggesting a structural misassignment.
activities against zoospores as well as potent antibacterial activity against S. aureus and Streptomyces viridochromogenes. 9 Several synthetic studies on juglomycins and their derivatives have been reported. 10 The synthesis of (±)-1 and (±)-2 was reported by Giles and co-workers. 11 Brimble and co-workers achieved the formal synthesis of (±)-1 and (±)-2 via oxidative fragmentation of furo [3,2-b] naphtho[2,1-d]-furans. 12, 13 The racemic and asymmetric synthesis of 1 using a reaction of a naphthol anion with a chiral aldehyde was reported by Kraus and co-workers.
14, 15 Min and co-workers synthesized (±)-1 from 1-hydroxy-5-methoxynaphthalene. 16 The Doẗz benzannulation route to the enantioselective synthesis of (−)-and (+)-1 has been reported by Fernandes and co-workers. 17−19 Both enantiomers of 3 and 4 were synthesized by the stereoselective aldol reaction of chiral sulfoxides with an aldehyde by our group. 20 During the course of our synthesis on juglorubin, 6 was obtained as a byproduct by treatment of 3 with a phosphate buffer (pH 8.5) under aerobic conditions. 21 In this paper, a unified approach toward the syntheses of juglomycins A−D, juglomycin C amide, khatmiamycin, and the structure proposed for juglomycin Z is reported. Through the synthesis of khatmiamycin and its 4-epimer, determination of the relative and absolute configuration of natural khatmiamycin has been achieved. The spectroscopic data for synthetic juglomycin Z and its methyl ester do not match those reported, suggesting that the structure assigned to juglomycin Z is incorrect.
■ RESULTS AND DISCUSSION
Our synthetic approach toward the syntheses of juglomycins A−D, Z, juglomycin C amide, and khatmiamycin is outlined in Scheme 1. The optically active compound 9 22 can be easily converted into the corresponding carboxylic acid (10) . We envisioned that 10 would serve as a potential common intermediate to access to the member of juglomycins and their related derivatives. Juglomycins A (1) and B (2) will be synthesized by formation of a lactone through benzylic oxidation of 10, followed by oxidation of naphthalene and removal of protective groups. Khatmiamycin (8) can be prepared by methanolysis of 1 or 2. Oxidation of the naphthalene in 10 and removal of the protective groups in 13 will afford juglomycin C (3). Epoxidation of 3 and isomerization of the corresponding epoxide 14 will give juglomycin D (6) . Amidation of 10, oxidation, and removal of the protective groups in 15 will afford juglomycin C amide (5) . Juglomycin Z (7) will be synthesized by introduction of the methyl group into the 3′-position of 13, followed by deprotection of the protective groups in 16.
The synthesis of juglomycins A (1) and B (2) is depicted in Scheme 2. Deprotection of the tert-butyldimethylsilyl (TBS) group in 9
22 with tetra-n-butylammonium fluoride (TBAF) gave the corresponding alcohol 17. Oxidation of the primary alcohol in 17 through Dess−Martin oxidation 23 and Pinnick oxidation 24 gave carboxylic acid 10. The desired intramolecular oxidative cyclization proceeded by treatment of 10 with 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) in the presence of molecular sieves 4A (MS4A) in dichloroethane to give 11 and 12 in 14 and 70% yields, respectively. The selectivity of this reaction can be rationalized by the following hypothesis: the formation of 11 would be disfavored by the pseudo-1,3-diaxial interaction between the naphthyl group and the hydrogen at the pseudo-axial position in intermediate I (Scheme 3). Oxidation of the 1,4-dimethoxynaphthalene moiety in 11 and 12 with ceric ammonium nitrate (CAN) followed by removal of two methoxymethyl (MOM) groups afforded 1 and 2, respectively. The spectroscopic data of synthetic 1 and 2 are identical with those of natural ones. 3 The synthesis and determination of the absolute configuration of khatmiamycin (8) were achieved (Scheme 4). Treatment of 1 with p-toluenesulfonic acid monohydrate (TsOH·H 2 O) in methanol at 50°C for 2.5 h gave 8 in 38% yield with 37% of recovered 1. Although several conditions were investigated to improve the yield of 8, no significant improvement was achieved. Increased reaction time and reaction temperature caused decomposition of 1 and 8. Methanolysis of 1 under basic conditions gave a complex mixture. We presume that the equilibrium between 1 and 8 exists. The 1 H and 13 C NMR spectra of synthetic 8 agreed with those reported for natural 8. 9 The specific rotation of synthetic 8 was determined to be [α] D 25 −103.3 (c 0.10, MeOH). The specific rotation for natural 8 was reported to be [α] D 25 −21.0 (c 0.10, MeOH). Although the specific rotation value of synthetic 8 was different from that of natural 8, the sign of synthetic 8 was identical to that of natural 8. The differences in the values should be due to the presence of impurities in natural 8. On the basis of these results, the absolute configuration of natural khatmiamycin was determined to be 3R,4R. Methanolysis of 2 under the same conditions as 1 gave 4-epi-8 in 43% yield with 19% of recovered 2. naphthalene ring in 10 with CAN followed by removal of the MOM groups gave juglomycin C (3). Oxidation of 3 with hydrogen peroxide in a phosphate buffer (pH = 8.5) afforded juglomycin D (6) . Treatment of 10 with ethyl chloroformate gave the corresponding mixed anhydride. Without further purification, the mixed anhydride was reacted with ammonia to afford amide 15. Oxidation of 15 with CAN followed by removal of the MOM groups gave juglomycin C amide (5) . The spectroscopic data for synthetic 3, 5, and 6 are identical with the reported data. 4, 7, 21 The synthesis of the structure proposed for juglomycin Z (7) is depicted in Scheme 6. Oxidation of the naphthalene ring in 10 with CAN gave the corresponding naphthoquinone derivative. Radical methylation 25 of the naphthoquinone by treatment with silver nitrate and potassium persulfate in the presence of acetic acid gave 16 in 30% yield over two steps. Removal of the MOM groups with TFA gave the proposed structure for juglomycin Z (7) in 34% yield. Unfortunately, the 1 H and 13 C NMR spectroscopic data for synthetic 7 do not match those reported for the natural one (Table S1 in the  Supporting Information) . 8 The A juglomycin Z isomer 20 and its methyl ester 21 were also synthesized (Scheme 7). Both 20 and 21 have a hydroxyl group at the 8′-position instead of the 5′-position. The hydroxyl group of 3-bromoplumbagin (22) 26 was protected as a MOM ether to give 23. Reduction of the 1,4-naphthoquinone in 23 with sodium hydrosulfite followed by methylation of two hydroxyl groups in the resultant hydroquinone gave 24. A Grignard reagent, which was prepared from 24, was treated with optically active epoxide 25 22 8 The results obtained in Schemes 6 and 7 indicate that the structure proposed for natural juglomycin Z is incorrect. The 1 H and 13 C NMR signals at the 4,1′,2′,3′,4′-positions as well as the methyl group at the 3′-position in synthetic 7 are quite different from those reported for natural juglomycin Z (Table  1 ). In particular, the 1 H and 13 C NMR signals of the methyl group at the 3′-position in synthetic 7 (δ H = 2.26 ppm; δ C = 12.7 ppm) are shifted upfield in comparison with those reported for 7 (δ H = 2.67 ppm; δ C = 18.5 ppm). These observations indicate that natural juglomycin Z does not have a methyl group at the 3′-positon. The 1 H and 13 C NMR signals at the 1′,2′,3′,4′-positions in natural 7 are quite different from those at the 1,2,3,4-positions reported for bhimamycin E (30) 27 and 2-methyl-3-acetoxy-5-methoxy-1,4-naphthoquinone (31) . 28 Furthermore, the chemical shifts of the methyl group in natural 7 are quite different from those derived from the methyl group in the acetyl group in 30 and 31. These spectral comparisons suggest that natural juglomycin Z does not possess an acetyl or acetoxy group at the 3′-position. Therefore, the structure for natural juglomycin Z still remains unclear.
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■ CONCLUSIONS 2-Alkyl-1,4-naphthoquinones generally act as electrophiles at their electron-deficient α,β-unsaturated ketone moieties. On the other hand, their tautomers, o-quinone methides, react as both nucleophiles and electrophiles. Natural 1,4-naphthoquinones undergo several biotransformations by both enzymatic and nonenzymatic modifications because of their high reactivities. Juglomycins have remarkable structural diversity by available modifications. 7 To date, 11 juglomycins (A−J and Z) have been isolated and characterized. 1, 2, 4, 8, 29 Related natural naphthoquinones such as frenolicins 30−32 and nanaomycins 33−36 have also been isolated ( Figure 2 ). 37 Thus, a divergent synthesis from a common intermediate will provide easy access to these natural products. 38 In this study, we demonstrated that compound 10 is a common intermediate for the divergent synthesis of juglomycins and their derivatives. The most significant feature of the approach described in this paper is that these natural products can be synthesized through only two to four steps from the common intermediate 10. Further synthetic studies toward related natural naphthoquinones and evaluation of the biological activities of synthetic compounds are currently ongoing in our laboratory.
■ EXPERIMENTAL SECTION
General Information. All solvents and reagents were used without further purification unless otherwise noted. Analytical TLC was performed using Silica gel 60 F 254 plates (0.25 mm, normal phase) and Silica gel 60RP-18 F 254S plates (0.25 mm, reverse phase). Normal phase flash column chromatography was performed using Silica gel 60 (particle size 40−63 μm; 230−400 mesh ASTM). Reverse phase flash column chromatography was performed using an octadecyl (C18) silica gel (particle size 20−30 μm). Melting point (mp) data were uncorrected. Specific rotations were recorded on a polarimeter and recorded as [α] D values (concentration in g/ 100 mL). IR spectra were recorded on an IR spectrometer using NaCl (neat) or KBr pellets (solid). NaClO 2 (80%, 1.33 g, 11.8 mmol) was added to a solution of the crude aldehyde 18, 2-methyl-2-butene (4.16 mL, 39.3 mmol), and NaH 2 PO 4 ·2H 2 O (3.06 g, 19.6 mmol) in tert-butyl alcohol/H 2 O (1:1, 240 mL) at 0°C. The mixture was stirred at rt for 1 h. The reaction was quenched by the addition of saturated aqueous NH 4 Cl solution. The resultant mixture was diluted with CHCl 3 . The organic layer was separated, washed with brine, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/EtOAc = 1/1 with 1% AcOH) to give 10 (1.31 g, 85% over two steps) as orange oil. (11) and (4R,5S)-5-[1′,4′-Dimethoxy-5′-( m e t h o x y m e t h o x y ) n a p h t h a l e n -2 ′ -y l ] -4 -(methoxymethoxy)dihydrofuran-2(3H)-one (12) . DDQ (1.38 g, 6.08 mmol) was added to a suspension of 10 (800 mg, 2.03 mmol) and MS4A (1 g) in ClCH 2 CH 2 Cl (150 mL) at rt. The mixture was refluxed by heating in an oil bath under a nitrogen atmosphere for 4.5 h. The mixture was cooled to rt and filtrated through a pad of Celite. The filtrate was diluted with CHCl 3 and water. The organic layer was separated, washed with brine, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/EtOAc = 2/1) to give 11 (107.8 mg, 14%) as orange oil and 12 (555.4 mg, 70%) as orange needles. Juglomycin A, 5-Hydroxy-2-[(2′R,3′R)-3′-hydroxy-5′-oxotetrahydrofuran-2′-yl]naphthalene-1,4-dione (1). CAN (140 mg, 0.26 mmol) was added to a solution of 11 (40.0 mg, 0.102 mmol) in a 1:1 mixture of MeCN and water (5 mL) at 0°C. The mixture was stirred at 0°C for 45 min. The reaction was quenched by the addition of water. The resultant mixture was diluted with CHCl 3 . The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated to give a crude naphthoquinone.
TFA (2 mL) was added to a solution of the crude naphthoquinone in CH 2 Cl 2 (6 mL) at 0°C. The mixture was stirred at rt for 5 h and concentrated under reduced pressure. (2) . CAN (297 mg, 0.542 mmol) was added to a solution of 12 (85.0 mg, 0.217 mmol) in a 1:1 mixture of MeCN and water (9 mL) at 0°C. The mixture was stirred at 0°C for 40 min. The reaction was quenched by the addition of water. The resultant mixture was diluted with CHCl 3 . The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated to give a crude naphthoquinone.
TFA (3 mL) was added to a solution of the crude naphthoquinone in CH 2 Cl 2 (9 mL) at 0°C. The mixture was stirred at rt for 4 h and concentrated under reduced pressure. Khatmiamycin, Methyl(3R,4R)-3,4-dihydroxy-4-(5′-hydroxy-1′,4′-dioxo-1′,4′-dihydronaphthalen-2′-yl)-butanoate (8) . TsOH·H 2 O (13.9 mg, 73.1 μmol) was added to a solution of 1 (20.0 mg, 73.0 μmol) in distilled MeOH (9 mL) at rt. The mixture was stirred at 50°C by heating in an oil bath for 2.5 h. The reaction was quenched by the addition of water. The resultant mixture was diluted with EtOAc. The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (toluene/EtOAc = 3/2) and preparative GPC (CHCl 3 ) to give 8 (8.4 mg, 38%) as yellow solids and recovered 1 (7.4 mg, 37% an oil bath for 2.5 h. The reaction was quenched by the addition of water. The resultant mixture was diluted with EtOAc. The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 Juglomycin C, (S)-3-Hydroxy-4-(5′-hydroxy-1′,4′-dioxo-1′,4′-dihydronaphthalen-2′-yl)butanoic Acid (3). CAN (417 mg, 0.761 mmol) was added to a solution of 10 (120 mg, 0.305 mmol) in a 1:1 mixture of MeCN and water (12 mL) at 0°C. The mixture was stirred at 0°C for 15 min. The reaction was quenched by the addition of water. The resultant mixture was diluted with CHCl 3 . The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated to give a crude naphthoquinone.
TFA (4 mL) was added to a solution of the crude naphthoquinone in CH 2 Cl 2 (12 mL) at 0°C. The mixture was stirred at rt for 2 h and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/EtOAc = 2/1) to give 3 (48.7 mg, 58% over two steps) as yellow solids. The 1 H and 13 C NMR spectra were identical with those of our authentic sample. 20 Juglomycin D, (S)-3-Hydroxy-4-(3′,5′-dihydroxy-1′,4′-dioxo-1′,4′-dihydronaphthalen-2′-yl)butanoic Acid (6). A 30% aqueous H 2 O 2 solution (48 μL, 0.423 mmol) was added in portions to a solution of 3 (100 mg, 0.362 mmol) in 1 M sodium phosphate buffer (pH 8.5, 18.9 mL). The mixture was stirred at rt for 5 h. The mixture was diluted with EtOAc. The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (CHCl 3 /MeOH = 10/1 with 1% AcOH) to give 6 (69.3 mg, 66%) as yellow solids. The A 25% aqueous NH 3 solution (12 mL) was added to a solution of the crude mixed anhydride in MeOH (18 mL) at 0°C
. The mixture was stirred at rt for 1.5 h. The mixture was diluted with CHCl 3 and water. The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 Juglomycin C Amide, (S)-3-Hydroxy-4-(5′-hydroxy-1′,4′-dioxo-1′,4′-dihydronaphthalen-2′-yl)butanamide (5) . CAN (348 mg, 0.635 mmol) was added to a solution of 15 (100 mg, 0.254 mmol) in a 1:1 mixture of MeCN and water (12 mL) at 0°C. The mixture was stirred at 0°C for 20 min. The reaction was quenched by the addition of water. The resultant mixture was diluted with CHCl 3 . The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated to give a crude naphthoquinone.
TFA (5 mL) was added to a solution of the crude naphthoquinone in CH 2 Cl 2 (10 mL) at 0°C. The mixture was stirred at rt for 1.5 h and concentrated under reduced pressure. for 30 min. The reaction was quenched by the addition of water. The resultant mixture was diluted with CHCl 3 . The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated to give a crude naphthoquinone.
A solution of the crude naphthoquinone and AgNO 3 (8.6 mg, 51 μmol) in a 1:1:1:1 mixture of AcOH, MeCN, CH 2 Cl 2 , and water (4 mL) was degassed. A solution of K 2 S 2 O 8 (82.2 mg, 0.304 mmol) in degassed water (6 mL) was added to the mixture at rt. The mixture was refluxed at 90°C by heating in an oil bath under a nitrogen atmosphere for 2.5 h. The resultant mixture was diluted with CHCl 3 and water. The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (toluene/EtOAc = 3/2 with 1% AcOH) to give 16 (11.5 mg, 30% over two steps) as brown oil. [ (5′-hydroxy-3′-methyl-1′,4′-dioxo-1′ ,4′-dihydronaphthalen-2′-yl)butanoic Acid (7). TFA (2 mL) was added to a solution of 16 (11.5 mg, 0.030 mmol) in CH 2 Cl 2 (6 mL) at 0°C
. The mixture was stirred at rt for 1 h and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (CHCl 3 /MeOH = 10/1) and preparative thin-layer chromatography (CHCl 3 /MeOH = 20/ 1 with 1% AcOH) to give 7 (3.0 mg, 34%) as yellow solids. mp 88−90°C, lit. Methyl (S)-3-Hydroxy-4-(5′-hydroxy-3′-methyl-1′,4′-dioxo-1′,4′-dihydronaphthalen-2′-yl)butanoate (19) . A 0.6 M solution of trimethylsilyldiazomethane in hexane (1.2 mL, 0.72 mmol) was added to a solution of 7 (3.0 mg, 10.3 μmol) in a 1:2 mixture of CH 2 Cl 2 and MeOH (3 mL). The mixture was stirred at rt for 35 min. The reaction was quenched by the addition of AcOH (2 mL). The resultant mixture was diluted with CHCl 3 and water. The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/EtOAc = 3/1) to give 19 (2.2 mg, 70%) as orange solids. mp 52−53°C, lit. 3-Bromo-1,4-dimethoxy-5-(methoxymethoxy)-2-methylnaphthalene (24) . NaH (60% dispersion in mineral oil, 593.3 mg, 14.8 mmol) was added to a solution of 22 26 (3.29 g, 12.3 mmol), tetra-n-butylammonium iodide (TBAI, 226 mg, 0.61 mmol), and chlorodimethyl ether (MOMCl, 1.6 mL, 20.9 mmol) in THF (200 mL) at 0°C. The mixture was stirred under an argon atmosphere at 0°C for 15 min and at rt for 15 min. The reaction was quenched by the addition of water. The resultant mixture was diluted with EtOAc. The organic layer was separated, washed with water and brine, dried over Na 2 SO 4 , and concentrated. The residue was washed with hexane to remove mineral oil to afford crude 23. This compound was used for the next reaction.
A solution of Na 2 S 2 O 4 (10.7 g, 61.6 mmol) in water (200 mL) was added to a solution of crude 23 in ether (200 mL) and CHCl 3 (40 mL). The biphasic solution was stirred vigorously at rt for 10 min. The organic layer was collected and washed with water and brine, dried over Na 2 SO 4 , and concentrated. The residue was used for the next reaction without further purification.
Dimethyl sulfate (9.4 mL, 98.5 mmol) and K 2 CO 3 (13.6 g, 98.5 mmol) were added to a solution of the crude hydroquinone in acetone (250 mL) under an argon atmosphere. The mixture was refluxed for 13.5 h and was cooled to rt. The reaction was quenched by the addition of water. The resultant mixture was diluted with EtOAc. The organic layer was separated, washed with 28% aqueous NH 3 solution, water and brine, dried over Na 2 SO 4 , and concentrated under reduced pressure. (S)-3-Hydroxy-4-(8-hydroxy-3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)butanoic Acid (20) . CAN (311 mg, 0.834 mmol) was added to a solution of 29 (136 mg, 0.333 mmol) in a 1:1 mixture of MeCN and water (5 mL) at 0°C. The mixture was stirred at 0°C for 15 min. The reaction was quenched by the addition of water. The resultant mixture was diluted with CHCl 3 . The aqueous layer was extracted with CHCl 3 three times. The combined organic layer was dried over Na 2 SO 4 and concentrated to give a crude naphthoquinone.
TFA (3 mL) was added to a solution of the crude naphthoquinone in CH 2 Cl 2 (12 mL) at 0°C. The mixture was stirred at rt for 5 h and concentrated under reduced pressure. 
